期刊文献+

2007-2011年血流感染病原菌分布及耐药率变迁情况分析 被引量:2

Analysis of the distribution and drug resistance of pathogens in bloodstream infection from 2007 to 2011
下载PDF
导出
摘要 目的探讨我院2007-2011年血流感染病原菌分布及耐药率情况,为临床经验用药提供依据。方法采用全自动血培养仪进行血液培养,阳性标本分离培养后用全自动微生物分析系统VITEK 2 Compact进行菌种鉴定,药物敏感性试验采用手工琼脂扩散敏感试验(kirbry-bauer,K-B)和仪器卡片法,对结果进行数据统计分析。结果 5年间我院血流感染的病原菌以革兰阴性杆菌为主占52.6%,革兰阳性菌和真菌分布占42.8%和4.6%;除金黄色葡萄球菌和肺炎克雷伯菌外,其他病原菌分离率无明显上升趋势,耐药分析显示耐药率整体稳定;病原菌对大部分临床常用抗生素具有较高的耐药率,未出现明显上升趋势。结论及时关注血流感染病原菌分布情况及耐药动态,对于控制耐药菌的传播、指导临床经验用药具有非常重要的意义。 Objective To investigate the distributions and drug resistance rates of pathogens isolated from blood infectious patients in our hospital from 2007 to 2011. Methods Bact/Alert 3D automatic blood culture system was applied for blood cultures and VITEK 2 Compact was used to identify the positive samples. The antimicrobial susceptibility tests were performed with Kirbry-Bauer (K-B) and VITEK 2 Compact antibiotic suseptibility test methods respectively. Results The Gram-negative bacteria, with the isolate rate 52.6% , were predominant among the blood infectious pathogens in the last five years. The proportions of Gram-positive bacteria and fungi were 42. 8% and 4.6%, respectively. The ratios were not obviously increased among the five years except for Staphylococcus aureus and Klebsiella pneumoniae. The data showed a relatively stable drug resis- tance rates on the whole. The pathogens presented higher resistance rates to majority antibiotic and no notable rising was happened. Conclusion The predominant bacteria were identical generally among different years and the isolation rates appeared no obviously increasing trend.
出处 《转化医学杂志》 2012年第3期164-167,共4页 Translational Medicine Journal
关键词 血流感染 病原菌 分布 耐药率 Bloodstream infection Pathogen Distribution Drug resistance rate
  • 相关文献

参考文献6

二级参考文献23

共引文献53

同被引文献18

  • 1潘晓龙,周东升,吴祥林,方平.从携带多种耐药基因认识鲍曼不动杆菌多重耐药性[J].江西医学检验,2006,24(1):3-6. 被引量:12
  • 2杜小幸,张幸国,周华,俞云松,陈亚岗,李兰娟.亚胺培南耐药鲍曼不动杆菌同源性及碳青霉烯酶研究[J].中国感染与化疗杂志,2006,6(4):231-235. 被引量:47
  • 3杨启文,王辉,徐英春,谢秀丽,孙宏莉,陈民钧.3种常见非发酵革兰阴性杆菌的体外药物敏感性[J].中国感染与化疗杂志,2007,7(3):198-201. 被引量:14
  • 4Gootz TD, Marra A. Acinetobacter baumannii : an emerging multidrug-resistant threat [ J ]. Expert Rev Anti Infect Ther, 2008,6 ( 3 ) : 309-325.
  • 5Adams D, Yee L, Rimmer JA, et al. Investigation and man- agement of an A. Baumannii outbreak in ICU [ J ]. Br J Nurs,2011,20(3 ) : 140,142,144-147.
  • 6Costa SF,Woodcock J,Gill M,et al. Outer-membrane pro- teins pattern and detection of beta-lactamases in clinical i- solates of imipenem-resistant Acinetobacter baumannii from Brazil [ J ]. Int J Antimicrob Agents, 2000,13 ( 3 ) : 175-182.
  • 7Limansky AS, Mussi MA, Viale AM. Loss of a 29-kilodal- ton outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance [ J ]. J Clin Microbiol, 2002,40( 12 ) :4776-4778.
  • 8Fern6ndez-Cuenca F, Martinez-Martinez L, Conejo MC, et al. Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii [ J ]. J Antimicrob Chemother, 2003,51 ( 3 ) :565-574.
  • 9Mahgoub S, Ahmed J, Glatt AE. Underlying characteristics of patients harboring highly resistant Acinetobacter baumanni[J]. Am J Infect Corntrol,2010,30(7) :386-390.
  • 10Limansky AS, Mussi MA, Viale AM. Loss of a 29-kilodalton outer membrane protein in Acinetobacter haurnannii is associat- ed with irnipenem resistance[J]. J Clin Microbiol,2002,40(12) : 4776-4778.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部